https://pexa.se/en/pexa-and-astrazeneca-extend-co-operation-agreement/2016-01-07T08:58:03+01:00https://pexa.se/en/product-ce-marked/2016-03-16T08:19:31+01:00https://pexa.se/en/161018-pexa-receives-horizon-2020-funding/2016-10-18T12:35:39+02:00https://pexa.se/en/170915-advancements-for-pexa-at-ers-the-worlds-largest-respiratory-congress/2017-09-15T13:22:36+02:00https://pexa.se/en/171016-pexa-recruit-expert-in-the-field-of-biomarker-discovery/2017-10-16T08:54:07+02:00https://pexa.se/en/pexa-receives-additional-order-from-united-kingdom/2018-09-24T10:49:21+02:00https://pexa.se/en/181227-pexa-recognized-as-one-of-the-top-20-medtech-solution-providers-in-europe-2018-by-medtech-outlook-magazine/2018-12-27T09:40:02+01:00https://pexa.se/en/190206-pexa-named-awardee-in-carcinogenic-exposure-meter-quickfire-challenge/2019-02-06T08:59:00+01:00https://pexa.se/en/191002-pexa-enters-into-a-research-collaboration-agreement-with-janssen-and-the-university-of-gothenburg-for-discovery-of-biomarkers-in-exhaled-air/2019-10-02T14:50:19+02:00https://pexa.se/en/additional-news/2021-06-04T12:34:41+02:00https://pexa.se/en/additional-press-releases/2021-06-04T13:12:55+02:00https://pexa.se/en/pexa-partnering-in-research-project-for-increased-understanding-of-the-work-environment-within-the-3d-printing-industry/2023-11-06T11:26:10+01:00https://pexa.se/en/scientific-article-demonstrates-that-pexa-can-enable-rapid-diagnosis-of-the-disease-state-pgd/2024-04-29T16:03:17+02:00https://pexa.se/en/scientific-review-article-summarizes-pexas-technology/2024-07-05T13:02:14+02:00https://pexa.se/en/pexa-ab-receives-eu-trademark-approval-for-the-name-pexa/2024-08-15T11:25:03+02:00https://pexa.se/en/pexa-exhibits-at-europes-largest-lung-congress/2024-09-07T10:05:46+02:00https://pexa.se/en/research-with-pexa-awarded-at-ers2024/2024-09-30T10:00:02+02:00https://pexa.se/en/u-s-agency-places-order-for-pexa-instrument-upgrade/2024-10-07T10:44:08+02:00https://pexa.se/en/seasons-greetings-from-pexa-advancing-lung-disease-research-and-diagnostics-together/2024-12-20T14:50:18+01:00https://pexa.se/en/new-study-highlights-pexas-potential-as-a-novel-method-for-non-invasive-measurement-of-drug-levels-in-the-lung/2025-01-15T10:27:59+01:00https://pexa.se/en/rising-lung-cancer-rates-among-non-smokers-highlight-the-need-for-early-detection/2025-02-04T16:48:52+01:00https://pexa.se/en/pexa-strengthens-ip-portfolio-with-european-patent-offices-intention-to-grant-for-non-invasive-analysis-of-small-airway-particles-during-medical-ventilation/2025-03-06T07:32:47+01:00https://pexa.se/en/new-research-from-lund-university-may-expand-the-donor-lung-pool-for-transplantation/2025-03-28T11:21:53+01:00https://pexa.se/en/aarhus-university-upgrades-its-pexa-instrument-continued-trust-in-groundbreaking-lung-research/2025-03-31T16:48:02+02:00https://pexa.se/en/pexa-takes-the-next-step-sharpening-focus-on-clinical-applications-in-lung-diagnostics/2025-05-06T13:54:10+02:00https://pexa.se/en/pexa-to-showcase-non-invasive-lung-research-platform-and-present-at-respiratory-innovation-summit-during-ats-2025/2025-05-15T11:28:23+02:00https://pexa.se/en/pexa-files-patent-to-enable-rna-fragmentomics-in-exhaled-air-unlocking-molecular-insights-from-the-small-airways/2025-05-20T11:42:17+02:00https://pexa.se/en/karolinska-institute-researchers-launch-pilot-study-using-pexa-technology-to-analyze-antibody-responses-in-the-lower-airways/2025-07-01T11:41:32+02:00https://pexa.se/en/pexa-signs-its-first-rental-and-data-sharing-agreement-in-australia/2025-08-27T17:23:00+02:00https://pexa.se/en/pexa-to-exhibit-at-the-worlds-largest-lung-cancer-congress-wclc-2025-in-barcelona/2025-08-28T13:01:39+02:00https://pexa.se/en/pexa-files-patent-application-for-biomarkers-enabling-early-detection-of-lung-cancer/2025-10-22T10:57:48+02:00https://pexa.se/en/pexa-awarded-sek-1-million-from-vinnova-for-the-next-step-toward-lung-cancer-diagnostics/2025-10-31T09:03:13+01:00https://pexa.se/en/sek-27-million-from-the-swedish-cancer-society-awarded-to-sandra-lindstedts-team-in-lund-for-early-detection-of-lung-cancer/2025-11-14T14:20:17+01:00https://pexa.se/en/pexas-research-instrument-for-lung-cancer-detection-highlighted-by-swedens-largest-radio-news-programme/2025-11-20T11:04:34+01:00https://pexa.se/en/wallenberg-fellow-utilizes-pexas-research-instrument-in-groundbreaking-vaccine-and-antibody-study-for-respiratory-infections/2025-12-18T09:42:48+01:00https://pexa.se/en/pexas-lung-cancer-research-instrument-featured-by-aftonbladet-swedens-largest-news-site/2026-01-09T10:25:02+01:00https://pexa.se/en/pexa-granted-u-s-patent-for-spot-technology-developed-to-enhance-analytical-capabilities-in-exhaled-breath/2026-01-14T09:03:35+01:00https://pexa.se/en/pexas-transformation-journey-toward-future-diagnostics-highlighted-by-medtech-magazine/2026-03-05T16:30:35+01:00https://pexa.se/en/pexa-founder-interviewed-in-swedens-largest-regional-newspaper-goteborgs-posten-focus-on-early-detection-of-lung-disease/2026-03-05T16:41:46+01:00https://pexa.se/en/pexa-receives-order-from-norways-national-occupational-health-institute-stami/2026-03-06T10:39:22+01:00https://pexa.se/en/pexa-highlights-the-potential-for-early-detection-of-lung-diseases-at-life-science-day-presentation-now-available-online/2026-03-18T11:16:56+01:00https://pexa.se/en/additional-funding-strengthens-a-growing-research-environment-in-orebro-where-pexa-is-used-in-multiple-studies/2026-04-20T09:29:17+02:00https://pexa.se/en/pexa-receives-order-from-german-federal-institute-baua-for-second-instrument/2026-05-21T16:59:25+02:00https://pexa.se/en/pexa-partner-in-dutch-precision-medicine-project-within-copd-and-interstitial-lung-diseases/2026-05-12T17:19:34+02:00https://pexa.se/en/tv4-news-highlights-research-where-pexas-technology-is-being-used-for-future-early-detection-of-lung-cancer/2026-05-25T12:52:19+02:00https://pexa.se/en/new-doctoral-thesis-strengthens-pexas-opportunities-in-lung-cancer-and-other-lung-diseases/2026-06-02T14:15:57+02:00https://pexa.se/en/u-s-government-agency-customer-orders-upgrade-of-existing-pexa-system/2026-06-11T15:19:11+02:00https://pexa.se/en/pexa-signs-agreement-with-global-pharmaceutical-company-for-10-instruments-for-clinical-multicenter-study-in-pulmonary-fibrosis-with-a-value-of-approximately-sek-7-5-million/2026-06-23T09:17:42+02:00https://pexa.se/en/pexa-receives-broad-attention-in-australia-seen-as-having-significant-potential-for-earlier-detection-of-silicosis/2026-08-19T12:21:54+02:00https://pexa.se/en/pexa-at-the-worlds-largest-respiratory-congress-three-accepted-abstracts-featuring-pexa-to-be-presented/2026-09-03T22:44:35+02:00https://pexa.se/en/strong-interest-in-pexas-technology-at-the-international-ers-respiratory-congress-in-barcelona/2026-10-06T17:03:47+02:00https://pexa.se/en/pexa-has-installed-a-second-system-for-the-german-federal-institute-for-occupational-safety-and-health-baua/2026-10-16T08:59:53+02:00https://pexa.se/en/pexa-strengthens-its-international-patent-portfolio-with-positive-patent-decisions-in-europe-and-china/2026-10-29T09:53:30+01:00https://pexa.se/en/breakthrough-study-strengthens-evidence-for-non-invasive-sampling-of-the-lungs-small-airways/2026-10-29T20:39:57+01:00